Utilizing CRP and D-dimer Levels for Assessing Cerebral Infarction Risk in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Retrospective Analysis - Scorecard - MDSpire
Advertisement
Utilizing CRP and D-dimer Levels for Assessing Cerebral Infarction Risk in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Retrospective Analysis
Clinical Scorecard: Utilizing CRP and D-dimer Levels for Assessing Cerebral Infarction Risk in Pediatric Patients with Mycoplasma pneumoniae Pneumonia: A Retrospective Analysis
At a Glance
Category
Detail
Condition
Key Mechanisms
Elevated CRP and D-dimer levels associated with increased risk of CI, supported by statistical analysis.
Target Population
Care Setting
Key Highlights
Cerebral infarction occurred in 0.3% of children with Mycoplasma pneumoniae pneumonia, with an odds ratio of 1.08 for CRP and 1.00026 for D-dimer.
Guideline-Based Recommendations
Diagnosis
Management
Timely diagnosis and treatment are crucial to prevent severe sequelae, including specific interventions based on CI risk.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Aggressive thrombolysis and anticoagulation may be necessary in cases of CI, particularly when elevated CRP and D-dimer levels are present.
Clinical Best Practices
Utilize CRP and D-dimer levels for early identification of CI risk, and conduct thorough neurological assessments including specific tests like CT or MRI.
